about
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activationThe structural basis for agonist and partial agonist action on a β(1)-adrenergic receptorNuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signalingBiophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug DesignThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsDivergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors.Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor.Noradrenalin and dopamine receptors both control cAMP-PKA signaling throughout the cerebral cortex.Discovery of regulators of receptor internalization with high-throughput flow cytometry.Characterization of a prawn OA/TA receptor in Xenopus oocytes suggests functional selectivity between octopamine and tyramineAre there functional β₃-adrenoceptors in the human heart?Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity.Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patientsEvolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Physiological implications of biased signaling at histamine H2 receptors.International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes.Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cellsChallenges in β(3)-Adrenoceptor Agonist Drug DevelopmentBiased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptorTwo serines in the distal C-terminus of the human ß1-adrenoceptor determine ß-arrestin2 recruitment.Propranolol decreases retention of fear memory by modulating the stability of surface glutamate receptor GluA1 subunits in the lateral amygdalaNorepinephrine potentiates proinflammatory responses of human vaginal epithelial cells.High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathyNew perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.Novel cAMP signalling paradigms: therapeutic implications for airway diseaseNew concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.Conformational selection or induced fit? 50 years of debate resolved.G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction.β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma.Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.Tissue functions mediated by beta(3)-adrenoceptors-findings and challenges.Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.
P2860
Q24303747-5C2DA843-9D97-413C-9B93-0A5B7A92C005Q24594844-BAB6FB86-4C59-460A-A16F-C9699C914817Q27026973-D3FE31EE-C6DF-4281-84C4-A1525C76D36AQ27676919-7981F95F-FBF2-48A1-820F-1591B79A82ACQ30486707-CE87D885-1B27-42E2-ABF6-3FAC6756AE3BQ31148493-57F75879-BB60-4FF2-987F-FE3C5A90716BQ33888491-49C6D139-3FD3-4BB7-A66D-490F2657FAD4Q34073689-2F3097E5-095A-4400-89A9-3CCA648DA515Q34327895-AB4AB7D2-2265-4A9E-8C17-8D7786D9052EQ34415488-F887D2EC-21A2-480A-8251-E6052739B044Q34588651-AC7A037E-B255-466D-A78A-35D28FA0AB79Q34760546-807D5EF6-5881-4E0A-9134-F7284A3E4019Q34830038-4793B1DF-6853-4615-83DB-FB9156650F86Q34837191-C54BF9F2-33B9-46C1-949F-27ADB5EBFD1DQ35161152-9F5C758D-5465-4A21-85EE-A0C1BC9141F9Q35383835-E8A9032E-66F8-49AA-B30F-C103E270243AQ35868142-9C20BECD-1198-491A-9358-A7E1E73C9A4DQ36245570-AA73AAB9-D959-4E93-B969-9D5A6F6B1B0CQ36296849-54414C4D-67F1-4830-84C0-3121C2C88830Q36327996-EBB8DFF8-C9BD-4EED-B584-AF4C82863240Q36342091-1BBC3A09-80D8-4D49-B926-6786551AA143Q36342155-D99A085B-B597-4350-813E-8ACE22D86C75Q36363295-86F4D289-7DD7-4CC6-9F04-5E905E1830F7Q36394973-28D0347E-95B0-45ED-8F20-FA3F1652E90BQ36844071-AB57CD46-8364-4AF8-BC9D-4B7A07FDB75BQ36961294-5C8521C9-BD46-421A-BE1A-2B0A39CF3D05Q37822833-D0321905-DC77-4001-8E06-AFB4AC53E0B8Q37937552-0C56F63A-0601-4358-A9C1-E5D6C0591E02Q37947662-6BF7F5D8-B958-4DC3-B451-91168DC8E6FBQ38044984-A6E325E8-41E6-40A6-9DE6-7F3B8FF92441Q38173671-6A7A6292-1179-483F-BC86-437B02BA01ACQ38336214-11B50AAA-BCE2-4467-A47B-B34BC598D31CQ38363774-C8DC73DC-A2CE-4E44-8972-ADC60F0A9CBAQ38580287-07CDCB5E-B2D3-4F8A-AEE7-62486031C966Q38742275-AF35EA0E-8867-4FEA-BC7C-D8AABDB53265Q38959067-048144FD-B1B4-40A0-AFE1-992E4B9220E6Q41619618-C40F412A-3135-4443-894D-D8C0129F1F92Q42001057-38912EC6-D926-43A8-B85F-65F18E311651Q42732323-2F716416-91BF-404F-B018-20232617E829Q42839797-91E893F4-FB1D-4A22-B3AB-7F6D7DFFC307
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ligand-directed signalling at beta-adrenoceptors
@ast
Ligand-directed signalling at beta-adrenoceptors
@en
type
label
Ligand-directed signalling at beta-adrenoceptors
@ast
Ligand-directed signalling at beta-adrenoceptors
@en
prefLabel
Ligand-directed signalling at beta-adrenoceptors
@ast
Ligand-directed signalling at beta-adrenoceptors
@en
P2093
P2860
P1476
Ligand-directed signalling at beta-adrenoceptors
@en
P2093
Bronwyn A Evans
Dana S Hutchinson
Masaaki Sato
Mohsin Sarwar
Roger J Summers
P2860
P304
P356
10.1111/J.1476-5381.2009.00602.X
P407
P577
2010-02-02T00:00:00Z